Adenosine A(2A) receptors in psychopharmacology: modulators of behavior, mood and cognition
- PMID: 20190961
- PMCID: PMC2769003
- DOI: 10.2174/157015909789152191
Adenosine A(2A) receptors in psychopharmacology: modulators of behavior, mood and cognition
Abstract
The adenosine A(2A) receptor (A(2A)R) is in the center of a neuromodulatory network affecting a wide range of neuropsychiatric functions by interacting with and integrating several neurotransmitter systems, especially dopaminergic and glutamatergic neurotransmission. These interactions and integrations occur at multiple levels, including (1) direct receptor- receptor cross-talk at the cell membrane, (2) intracellular second messenger systems, (3) trans-synaptic actions via striatal collaterals or interneurons in the striatum, (4) and interactions at the network level of the basal ganglia. Consequently, A(2A)Rs constitute a novel target to modulate various psychiatric conditions. In the present review we will first summarize the molecular interaction of adenosine receptors with other neurotransmitter systems and then discuss the potential applications of A(2A)R agonists and antagonists in physiological and pathophysiological conditions, such as psychostimulant action, drug addiction, anxiety, depression, schizophrenia and learning and memory.
Keywords: A2A receptor; Adenosine; amphetamine; anxiety; caffeine; cocaine; depression; dopamine; glutamate.; psychostimulant; schizophrenia.
Similar articles
-
Anatomy of adenosine A2A receptors in brain: morphological substrates for integration of striatal function.Neurology. 2003 Dec 9;61(11 Suppl 6):S12-8. doi: 10.1212/01.wnl.0000095205.33940.99. Neurology. 2003. PMID: 14663003 Review.
-
Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology.Brain Res Rev. 2008 Aug;58(2):415-52. doi: 10.1016/j.brainresrev.2007.11.007. Epub 2008 Jan 28. Brain Res Rev. 2008. PMID: 18222544 Review.
-
Adenosine A(2A)-cannabinoid CB(1) receptor interaction: an integrative mechanism in striatal glutamatergic neurotransmission.Brain Res. 2012 Oct 2;1476:108-18. doi: 10.1016/j.brainres.2012.04.051. Epub 2012 May 4. Brain Res. 2012. PMID: 22565012 Review.
-
Pre-synaptic adenosine A2A receptors control cannabinoid CB1 receptor-mediated inhibition of striatal glutamatergic neurotransmission.J Neurochem. 2011 Jan;116(2):273-80. doi: 10.1111/j.1471-4159.2010.07101.x. Epub 2010 Dec 2. J Neurochem. 2011. PMID: 21062287
-
Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation.J Neurochem. 2004 Nov;91(4):873-80. doi: 10.1111/j.1471-4159.2004.02761.x. J Neurochem. 2004. PMID: 15525341
Cited by
-
Deletion of striatal adenosine A(2A) receptor spares latent inhibition and prepulse inhibition but impairs active avoidance learning.Behav Brain Res. 2013 Apr 1;242:54-61. doi: 10.1016/j.bbr.2012.12.024. Epub 2012 Dec 28. Behav Brain Res. 2013. PMID: 23276608 Free PMC article.
-
Sleep and alertness disturbance and substance use disorders: A bi-directional relation.Pharmacol Biochem Behav. 2021 Apr;203:173153. doi: 10.1016/j.pbb.2021.173153. Epub 2021 Feb 12. Pharmacol Biochem Behav. 2021. PMID: 33582097 Free PMC article. Review.
-
Adenosine Actions on Oligodendroglia and Myelination in Autism Spectrum Disorder.Front Cell Neurosci. 2018 Dec 7;12:482. doi: 10.3389/fncel.2018.00482. eCollection 2018. Front Cell Neurosci. 2018. PMID: 30581380 Free PMC article. Review.
-
Impact of an Adenosine A2A Receptor Agonist and Antagonist on Binding of the Dopamine D2 Receptor Ligand [11C]raclopride in the Rodent Striatum.Mol Pharm. 2022 Aug 1;19(8):2992-3001. doi: 10.1021/acs.molpharmaceut.2c00450. Epub 2022 Jul 18. Mol Pharm. 2022. PMID: 35849844 Free PMC article.
-
Targeting purinergic receptors to suppress the cytokine storm induced by SARS-CoV-2 infection in pulmonary tissue.Int Immunopharmacol. 2021 Nov;100:108150. doi: 10.1016/j.intimp.2021.108150. Epub 2021 Sep 13. Int Immunopharmacol. 2021. PMID: 34537482 Free PMC article. Review.
References
-
- Agnati LF, Fuxe K, Zini I, Lenzi P, Hokfelt T. Aspects on receptor regulation and isoreceptor identification. Med. Biol. 1980;58:182–187. - PubMed
-
- Akhondzadeh S, Safarcherati A, Amini H. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2005;29:253–259. - PubMed
-
- Akhondzadeh S, Shasavand E, Jamilian H, Shabestari O, Kamalipour A. Dipyridamole in the treatment of schizophrenia: adenosine-dopamine receptor interactions. J. Clin. Pharm. Ther. 2000;25:131–137. - PubMed
-
- Alsene K, Deckert J, Sand P, de Wit H. Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology. 2003;28:1694–1702. - PubMed
-
- Alsene KM, Wachtel S, Jurgen D, Wit Hd. Annual meeting for Society for Neuroscience. Orlando, Florida: 2002. Polymorphisms in the adenosine A2A receptor gene are related to caffeine-induced anxiety.
Grants and funding
LinkOut - more resources
Full Text Sources